atazanavir accord 200 mg
pharmadox healthcare ltd. - malta - atazanavirum - caps. - 200mg - antivirale cu actiune directa inhibitori de proteaza
atazanavir accord 300 mg
pharmadox healthcare ltd. - malta - atazanavirum - caps. - 300mg - antivirale cu actiune directa inhibitori de proteaza
atazanavir zentiva 150 mg
zentiva, k.s. - republica ceha - atazanavirum - caps. - 150mg - antivirale cu actiune directa inhibitori de proteaza
atazanavir zentiva 200 mg
zentiva, k.s. - republica ceha - atazanavirum - caps. - 200mg - antivirale cu actiune directa inhibitori de proteaza
atazanavir zentiva 300 mg
zentiva, k.s. - republica ceha - atazanavirum - caps. - 300mg - antivirale cu actiune directa inhibitori de proteaza
atazanavir sandoz 100 mg
remedica ltd - cipru - atazanavirum - caps. - 100mg - antivirale cu actiune directa inhibitori de proteaza
atazanavir sandoz 150 mg
remedica ltd - cipru - atazanavirum - caps. - 150mg - antivirale cu actiune directa inhibitori de proteaza
atazanavir sandoz 200 mg
remedica ltd - cipru - atazanavirum - caps. - 200mg - antivirale cu actiune directa inhibitori de proteaza
atazanavir sandoz 300 mg
remedica ltd - cipru - atazanavirum - caps. - 300mg - antivirale cu actiune directa inhibitori de proteaza
epclusa
gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatita c, cronică - antivirale pentru uz sistemic - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 și 5.